JUST IN: COVID-19 vaccine coming by April for emergency situations and clinical trials

Chinese officials say they’ll have a coronavirus vaccine ready next month for emergency situations and clinical trials.

Eight institutes in the country are working on five approaches to inoculations in an effort to combat COVID-19, according to the South China Morning Post.

The contagious illness has sickened more 162,651 people globally with 6,069 deaths. 76,219 of the cases have recovered fully. Most of the cases have been in mainland China.

“According to our estimates, we are hopeful that in April some of the vaccines will enter clinical research or be of use in emergency situations,” Zheng Zhongwei, director of the National Health Commission’s Science and Technology Development Center, said Friday.

While it would take at least 12 to 18 months to ensure the vaccines are safe for the general public, under Chinese law, they can be deployed earlier for urgent use in a major public health emergency, as long as the benefits outweigh the risks.

Zheng waved off concerns about the safety of the vaccines, saying they were being developed in ­accordance with “scientific and standardized technical requirements,” The Australian reported.

In the US, Massachusetts-based biotechnology company Moderna Inc. shipped its vaccine to the National Institute of Allergy and Infectious Diseases for testing late last month. Initial results could be released by July or August.

Check This Out: JUST IN: Gov’t shuts down all Public and Private Educational Institutions Indefinitely over COVID-19 Scare (VIDEO)

Source: Nypost.com

Get the Ghana Education Service New Standard – Based Scheme of Learning (SOL) HERE

Get the Ghana Education Service New Standard – Based Curriculum HERE

Get the  WAEC Marking Schemes HERE

Get the NaCCA/GES Standard -Based Lesson Plans HERE

Get the WAEC BECE, WASSCE, NTC Licensure Exam and Teachers’ Promotion Exam Past Questions HERE


Discover more from EducationGhana

Subscribe to get the latest posts sent to your email.

What's your take on this Latest Development?